Endocrine Disrupting Chemicals, Transgenerational Epigenetics and Metabolic Diseases.
Aliya G. Feroe(Mayo Clinic), Patricia Ruiz(Centers for Disease Control and Prevention), David Albuquerque(University of Coimbra), Richard D. Broene(Bowdoin College)
PubMed
November 1, 2017
Cited by 7
Related Papers
Antimony and sleep-related disorders: NHANES 2005–2008
|Environmental Research|2017|109
Modeling Cadmium Exposures in Low- and High-Exposure Areas in Thailand
|Environmental Health Perspectives|2013|101
Acrolein metabolites, diabetes and insulin resistance
|Environmental Research|2016|77